Shanghai Henlius Biotech, Inc.’s IPO On The Hong Kong Stock Exchange

Freshfields Bruckhaus Deringer has advised Shanghai Henlius Biotech, Inc. on the global offering and listing of its H shares on the Hong Kong Stock Exchange. The…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here